220 related articles for article (PubMed ID: 32228151)
1. The
Yin N; Sherman SI; Pak Y; Litofsky DR; Gianoukakis AG;
Thyroid; 2020 Oct; 30(10):1490-1495. PubMed ID: 32228151
[No Abstract] [Full Text] [Related]
2. Significance of "de novo" appearance of thyroglobulin antibodies in patients with differentiated thyroid cancer.
Scappaticcio L; Trimboli P; Verburg FA; Giovanella L
Int J Biol Markers; 2020 Sep; 35(3):41-49. PubMed ID: 33073682
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
[TBL] [Abstract][Full Text] [Related]
4. Investigating Antithyroglobulin Antibody As a Prognostic Marker for Differentiated Thyroid Cancer: A Meta-Analysis and Systematic Review.
Lee ZJO; Eslick GD; Edirimanne S
Thyroid; 2020 Nov; 30(11):1601-1612. PubMed ID: 32345152
[No Abstract] [Full Text] [Related]
5. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
[TBL] [Abstract][Full Text] [Related]
7. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
[TBL] [Abstract][Full Text] [Related]
8. Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
Görges R; Maniecki M; Jentzen W; Sheu SN; Mann K; Bockisch A; Janssen OE
Eur J Endocrinol; 2005 Jul; 153(1):49-55. PubMed ID: 15994745
[TBL] [Abstract][Full Text] [Related]
9. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
10. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
Phan HT; Jager PL; van der Wal JE; Sluiter WJ; Plukker JT; Dierckx RA; Wolffenbuttel BH; Links TP
Eur J Endocrinol; 2008 Jan; 158(1):77-83. PubMed ID: 18166820
[TBL] [Abstract][Full Text] [Related]
11. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812
[TBL] [Abstract][Full Text] [Related]
12. Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
Jo K; Kim MH; Lim Y; Jung SL; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
Eur J Endocrinol; 2015 Oct; 173(4):489-97. PubMed ID: 26208979
[TBL] [Abstract][Full Text] [Related]
13. Predicting clinical outcomes of patients with serum thyroglobulin antibodies after thyroidectomy for differentiated thyroid cancer: a retrospective study from a UK regional center.
Anderson H; Lim KH; Gull S; Oprean R; Spence K; Cvasciuc T
Minerva Endocrinol (Torino); 2024 Mar; 49(1):60-68. PubMed ID: 37428110
[TBL] [Abstract][Full Text] [Related]
14. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
[TBL] [Abstract][Full Text] [Related]
15. Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer.
Zhang X; Zhang X; Chang Z; Wu C; Guo H
J BUON; 2018; 23(5):1467-1471. PubMed ID: 30570874
[TBL] [Abstract][Full Text] [Related]
16. High Thyroglobulin Antibody Levels Increase the Risk of Differentiated Thyroid Carcinoma.
Qin J; Yu Z; Guan H; Shi L; Liu Y; Zhao N; Shan Z; Han C; Li Y; Teng W
Dis Markers; 2015; 2015():648670. PubMed ID: 26600670
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer.
Jo K; Kim MH; Ha J; Lim Y; Lee S; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
Clin Endocrinol (Oxf); 2017 Sep; 87(3):292-299. PubMed ID: 28493284
[TBL] [Abstract][Full Text] [Related]
18. Thyroglobulin antibody (TgAb) methods - Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer.
Spencer C; Fatemi S
Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):701-12. PubMed ID: 24094640
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.
Chung JK; Park YJ; Kim TY; So Y; Kim SK; Park DJ; Lee DS; Lee MC; Cho BY
Clin Endocrinol (Oxf); 2002 Aug; 57(2):215-21. PubMed ID: 12153600
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer.
Jo K; Lim DJ
Korean J Intern Med; 2018 Nov; 33(6):1050-1057. PubMed ID: 30396251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
